Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order
Mucorales. The exact incidence of mucormycosis in India is unknown due to the lack of …

Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached
epidemic proportion during India's second wave of COVID-19 pandemic, with several risk …

Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and
mortality. A change in the epidemiology of mucormycosis has been observed in recent years …

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

The diagnosis and treatment of mucormycosis are challenging. The incidence of the disease
seems to be increasing. Hematological malignancies are the most common underlying …

Mucormycosis due to Mucorales is reported at large numbers in uncontrolled diabetics
across India, but systematic multicenter epidemiological study has not been published yet …

Background Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The
SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients …

Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Invasive mucormycosis is a life-threatening fungal infection that most frequently occurs in
patients with underlying comorbidities impacting immune system function. 1–4 Rhino-orbital …